Loading…
Reported covered position: 2006-2007: Counselor to the Honorable Michael O. Leavitt ; ; (Immediate Office of the Secretary); US. Dept. Of Health and ; ; Human Serivces; 2004-2006: Assoc Commissioner for External ; ; Relations, U.S. FDA; 1998-1999: Majority Counsel, Armed ; ; Service Committee, U.S. House of Reprsentatives
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2024 · first_quarter · 1T
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests HR 3207.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207 Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. No. 112-144, 126 Stat. 993 (2012)
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: GENOMIC HEALTH INC. · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests. Tricare payment of laboratory developed tests. HR 3207
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests HR 3207.
Modernizing Laboratory Test Standards for Patients Act of 2011
Client: COALITION FOR 21ST CENTURY MEDICINE · Firm: GOLDBUG STRATEGIES LLC
FDA regulation of laboratory developed tests. Medicare reimbursement for laboratory developed tests HR 3207.
2023 · fourth_quarter · 4A
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2023 · fourth_quarter · Q4
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2023 · third_quarter · Q3
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2023 · second_quarter · Q2
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2023 · first_quarter · Q1
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2022 · fourth_quarter · 4A
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2022 · fourth_quarter · Q4
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2022 · third_quarter · Q3
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2022 · second_quarter · Q2
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2022 · first_quarter · Q1
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2021 · fourth_quarter · Q4
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2021 · third_quarter · Q3
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2021 · second_quarter · Q2
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2021 · first_quarter · Q1
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2020 · fourth_quarter · Q4
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2020 · third_quarter · Q3
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2020 · second_quarter · Q2
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2020 · first_quarter · Q1
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2020 · first_quarter · 1T
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Food & Drug Administration (FDA)
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2019 · fourth_quarter · Q4
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Food & Drug Administration (FDA)
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2019 · fourth_quarter · Q4
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Food & Drug Administration (FDA)
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2019 · fourth_quarter · Q4
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2019 · third_quarter · Q3
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Food & Drug Administration (FDA)
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2019 · third_quarter · Q3
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Food & Drug Administration (FDA)
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2019 · third_quarter · Q3
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2019 · second_quarter · Q2
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Food & Drug Administration (FDA)
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2019 · second_quarter · Q2
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Food & Drug Administration (FDA)
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2019 · second_quarter · Q2
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2019 · first_quarter · Q1
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Food & Drug Administration (FDA)
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2019 · first_quarter · Q1
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Food & Drug Administration (FDA)
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2019 · first_quarter · Q1
in vitro diagnostics, clinical laboratories, digital health regulation
in vitro diagnostics, clinical laboratories, digital health regulation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2018 · fourth_quarter · Q4
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2018 · fourth_quarter · Q4
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: Food & Drug Administration (FDA)
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2018 · fourth_quarter · Q4
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health. VALID Act
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software. VALID Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2018 · third_quarter · Q3
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2018 · third_quarter · Q3
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: Food & Drug Administration (FDA)
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2018 · third_quarter · Q3
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2018 · second_quarter · Q2
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2018 · second_quarter · Q2
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: Food & Drug Administration (FDA)
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2018 · second_quarter · Q2
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2018 · first_quarter · Q1
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2018 · first_quarter · Q1
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2018 · first_quarter · Q1
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2017 · fourth_quarter · Q4
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2017 · fourth_quarter · Q4
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2017 · fourth_quarter · Q4
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software, digital health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2017 · third_quarter · Q3
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2017 · third_quarter · Q3
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2017 · third_quarter · Q3
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2017 · second_quarter · Q2
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2017 · second_quarter · Q2
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC. via GOLDBUG STRATEGIES LLC
2017 · second_quarter · Q2
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2017 · second_quarter · 2A
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2017 · second_quarter · Q2
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2017 · first_quarter · Q1
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2017 · first_quarter · Q1
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC. via GOLDBUG STRATEGIES LLC
2017 · first_quarter · Q1
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2017 · first_quarter · Q1
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Regulation of in vitro diagnostic products, LDTs, medical device, and bioinformatics/software.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2016 · fourth_quarter · Q4
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2016 · fourth_quarter · Q4
FDA regulation of medical devices: software as medical device, laboratory developed tests, in vitro diagnostic products;
FDA regulation of medical devices: software as medical device, laboratory developed tests, in vitro diagnostic products;
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC. via GOLDBUG STRATEGIES LLC
2016 · fourth_quarter · Q4
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, regulatory policy for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2016 · fourth_quarter · Q4
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, software for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, software for laboratory developed tests and in vitro diagnostic products.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2016 · third_quarter · Q3
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2016 · third_quarter · Q3
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products;
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products;
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC. via GOLDBUG STRATEGIES LLC
2016 · third_quarter · Q3
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2016 · third_quarter · Q3
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2016 · second_quarter · Q2
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2016 · second_quarter · Q2
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2016 · second_quarter · Q2
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products;
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products;
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC. via GOLDBUG STRATEGIES LLC
2016 · second_quarter · Q2
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2016 · second_quarter · Q2
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2016 · first_quarter · Q1
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2016 · first_quarter · Q1
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products;
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products;
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC. via GOLDBUG STRATEGIES LLC
2016 · first_quarter · Q1
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2016 · first_quarter · Q1
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CURE FORWARD via GOLDBUG STRATEGIES LLC
2015 · fourth_quarter · Q4
FDA regulation of medical devices, software, in vitro diagnostic products; 21st Century Cures Initiative, Healthier Americans Initiative
FDA regulation of medical devices, software, in vitro diagnostic products; 21st Century Cures Initiative, Healthier Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2015 · fourth_quarter · Q4
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2015 · fourth_quarter · Q4
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; FDA related provisions of 21st Century Cures Initiative and Healthy Americans Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; FDA related provisions of 21st Century Cures Initiative and Healthy Americans Initiative
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC. via GOLDBUG STRATEGIES LLC
2015 · fourth_quarter · Q4
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2015 · fourth_quarter · Q4
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CURE FORWARD via GOLDBUG STRATEGIES LLC
2015 · third_quarter · Q3
FDA regulation of medical devices, software, in vitro diagnostic products; 21st Century Cures Initiative, Healthier Americans Initiative
FDA regulation of medical devices, software, in vitro diagnostic products; 21st Century Cures Initiative, Healthier Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2015 · third_quarter · Q3
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2015 · third_quarter · Q3
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative; Healthy Americans Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative; Healthy Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC. via GOLDBUG STRATEGIES LLC
2015 · third_quarter · Q3
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2015 · third_quarter · 3A
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2015 · third_quarter · Q3
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2015 · second_quarter · Q2
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CURE FORWARD via GOLDBUG STRATEGIES LLC
2015 · second_quarter · Q2
FDA regulation of medical devices, software, in vitro diagnostic products; 21st Century Cures Initiative, Healthier Americans Initiative
FDA regulation of medical devices, software, in vitro diagnostic products; 21st Century Cures Initiative, Healthier Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2015 · second_quarter · Q2
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative; Healthy Americans Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative; Healthy Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2015 · second_quarter · Q2
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC. via GOLDBUG STRATEGIES LLC
2015 · second_quarter · Q2
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2015 · first_quarter · Q1
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative, Healthy Americans Initiative
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CURE FORWARD via GOLDBUG STRATEGIES LLC
2015 · first_quarter · Q1
FDA regulation of medical devices, software, in vitro diagnostic products; 21st Century Cures Initiative, Healthier Americans Initiative
FDA regulation of medical devices, software, in vitro diagnostic products; 21st Century Cures Initiative, Healthier Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LIFE TECHNOLOGIES/THERMO FISHER via GOLDBUG STRATEGIES LLC
2015 · first_quarter · Q1
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative; Healthy Americans Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative; Healthy Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2015 · first_quarter · 1A
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GENOMIC HEALTH INC. via GOLDBUG STRATEGIES LLC
2015 · first_quarter · Q1
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR 21ST CENTURY MEDICINE via GOLDBUG STRATEGIES LLC
2015 · first_quarter · Q1
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Senate Healthy Americans Initiative,regulatory policies for laboratory developed tests and in vitro diagnostic products.
FDA regulation of laboratory developed tests, in vitro diagnostics and medical devices. 21st Century Cures Initiative, Healthy Americans Initiative; regulatory policy for laboratory developed tests and in vitro diagnostic products.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CURE FORWARD via GOLDBUG STRATEGIES LLC
2014 · fourth_quarter · Q4
FDA regulation of medical devices, software, in vitro diagnostic products; 21st Century Cures Initiative
FDA regulation of medical devices, software, in vitro diagnostic products; 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
23ANDME, INC. via GOLDBUG STRATEGIES LLC
2014 · fourth_quarter · Q4
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative
FDA regulation of medical devices, software, laboratory developed tests, in vitro diagnostic products; 21st Century Cures Initiative
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE